StockVS

NASDAQ · Household & Personal Products · USD

Park Ha Biological Technology Co., Ltd. (BYAH) Stock Analysis

Park Ha Biological Technology Co., Ltd. (BYAH) is a Household & Personal Products stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

BYAH

$2.49

+$0.12 (+5.06%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BYAH with… →

BYAH Key Statistics

As of Oct 21, 2026
Trading
Open
$2.30
Previous Close
$2.37
Day's Range
2.30–2.49
52-Week Range
1.90–171.60
Volume
7.39K
Valuation
Market Cap
$46.24M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
18.18
EPS (ttm)Profit attributable to each share over the last twelve months.
−37.53
Financials (FY)
Revenue (FY)
$2.52M+6.00%
Net Income (FY)
−$24.36M−5,191.25%
Profit marginThe share of revenue left as profit after all costs and taxes.
−214.17%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
19.46M
1-Year Return
−98.43%
Dividend and dates
Avg Volume
453.39K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BYAH closed at $2.49, −98.43% over 1 year.

Park Ha Biological Technology Co., Ltd. (BYAH) has a market capitalization of $46.24M.

In fiscal 2025, BYAH reported revenue of $2.52M.

BYAH Stock Return by Calendar Year

Park Ha Biological Technology Co., Ltd. (BYAH) return since Dec 2024: what $10,000 became

1 year
$10,000 $157
−98.43%
Since Dec 2024
$10,000 $15
−99.85%

If you had invested $10,000 in Park Ha Biological Technology Co., Ltd. (BYAH) at the close on December 27, 2024, the earliest close on record here, it would have been worth $15 at the close on October 21, 2026: −99.85% in total, −97.19% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−96.08%
2025−97.47%
2024 (partial year)+54.55%

As of October 21, 2026.

BYAH Revenue and Earnings by Fiscal Year

FY ends October
Fiscal yearRevenueNet incomeNet margin
2025$2.52M−$24.36M−965.0%
2024$2.38M$478.56K20.1%
2023$2.46M$852.04K34.6%
2022$1.92M$191.30K10.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.52M$2.38M−$24.15M−$24.36M−965.0%
2024$2.38M$2.19M$793.71K$478.56K20.1%
2023$2.46M$2.15M$1.18M$852.04K34.6%
2022$1.92M$1.41M$197.02K$191.30K10.0%

Annual figures as reported, in the company's reporting currency. As of October 31, 2025.

BYAH Valuation vs Household & Personal Products Median

Median of 32 stocks
MetricBYAHHousehold & Personal Products medianvs median
P/S ratio18.181.3313.6x the median
Profit margin−214.17%1.72%215.9 pts below

Medians across 32 Household & Personal Products stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values Park Ha Biological Technology Co., Ltd. (BYAH) at $46.24M. It is classified in the Household & Personal Products industry, within the Consumer Defensive sector. The company reports 41 employees.

BYAH last closed at $2.49 on October 21, 2026. That is +$0.12 (+5.06%) against the previous close. Over the past 52 weeks the price has ranged from $1.90 to $171.60. The latest close sits 31.05% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $2.52M. Against the prior fiscal year total of $2.38M, that is a change of +6.00%. The same year closed with a net loss of $24.36M. Profit margin runs at −214.17%. That is 215.9 percentage points below the Household & Personal Products median of 1.72%. Earnings per share on a trailing basis come to −37.53.

Across the 4 fiscal years on file, revenue moves from $1.92M in 2022 to $2.52M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 18.18 times revenue. On price-to-sales that is 13.6 times the Household & Personal Products median of 1.33. The medians here are taken across 32 Household & Personal Products companies that report the metric.

Over the trailing twelve months the total return is −98.43%. The stored price history starts on December 27, 2024, and the total return since then is −99.85%. Annualized volatility over the trailing 1 year is 197.61%.

Growth & Income

No dividend is on file for BYAH.

The record holds one complete calendar year, 2025, which returned −97.47%. So far in 2026 the total return is −96.08%.

Peer Comparison

Park Ha Biological Technology Co., Ltd. (BYAH) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Park Ha Biological Technology Co., Ltd. BYAH $46.24M —
The Procter & Gamble Company PG $364.29B 23.7
Unilever PLC UL $138.69B 13.0
Colgate-Palmolive Company CL $75.02B 37.1

The Household & Personal Products industry average P/E ratio is 22.9x. Park Ha Biological Technology Co., Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Household & Personal Products Stocks

View all Household & Personal Products stocks →

Popular Consumer Defensive Stocks

View all Consumer Defensive stocks →

About Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Visit website →